Skip to main content

Search

About Us
Our Credo
Board of Directors

Committees of Board

Management Council
Manufacturing
Quality
Code of Conduct
Our History - Cipla Archives

Scientist with a Heart- Dr. Y K Hamied

90 years of caring for life
Legacy of Care | Comic Book
Milestones and Awards
Our Presence
Australia
Brazil
Europe
Germany
Ghana
Kenya
Malaysia
Morocco
Nepal
South Africa
Spain
Sri Lanka
Uganda
United Kingdom
USA
Our Offerings
Our Therapies

Respiratory

Asthma
Paediatric Asthma
COPD
Nebulization

HIV/AIDS
Oncology
Other Therapies

AMR
Cipla Generics

Products

Cipcal
Easylax
Easylax-L

OTC – Cipla Health
Cipla Diagnostics
API
Covid Care
Investors
Financials & Filings

Quarterly Results
Investor Presentation
Annual Reports
Scheme of Arrangement

Disclosure under regulation 46 of SEBI LODR
Corporate Governance
Cipla at a Glance

Board Of Directors

Investor Resources
Shareholding Pattern
Intimation to Stock Exchange
Unclaimed Data
Investor Contacts
Disclaimer
Sustainability
Championing Climate Positivity
Accelerated Community Well-being

Community Initiatives
Employee Initiatives

Raising the Bar on Governance
Enhancing Access and Affordability
Careers
Life at Cipla
Business Functions
Diversity & Inclusion
Holistic Wellbeing
Cipla University
Join Us
Media Centre
Media Releases
In The News
Corporate Social Responsibility
Cipla Foundation

Cipla Palliative Care

Annual Update 2025
Annual Update 2023-24

CSR Policy
CSR Committee
Approved CSR Projects

2025-26
2024-25
2023-24
2022-23
2021-22
Contact Us
Global
Brazil
Kenya
South Africa
Sri Lanka
United Kingdom
USA

Breadcrumb

Home
investors
intimation stock exchanges

Intimation to stock Exchanges

Quick Explore

Corporate Governance
Shareholding Pattern
Investor contact

Year

Intimation to Stock Exchange for 2026-2027

Newpaper Advertisement regarding opening of special window for lodgement of transfer and dematerialisation of physical shares

Intimation for appointment of Statutory Auditors

ESG Rating assigned by ESG Risk Assessments & Insights Limited

Public Notice – Transfer of equity shares to IEPF - 2026

Grant of Stock Options and employee stock appreciation rights

Appointment of Mr Shivam Puri as the Chief Executive Officer – One India Business & Management Council member, designated as SMP

Update on USFDA Inspection at the Company’s manufacturing facility in Verna, Goa, India

Corrigendum to the intimation dated 1st June, 2026 regarding ‘Notice of the 90th Annual General Meeting along with Integrated Annual Report for FY 2025-26

Communication on tax deduction at source on final dividend for FY 2025-26

Allotment of 44,770 equity shares under ESOS 2013-A Scheme and the Cipla ESAR Scheme 2021 of the Company

Pagination

Current page 1
Page 2
Page 3
Next page
Last page

BSE and NSE Quotes by TradingView

The displayed data is not in real time and may have streaming delays.

Corporate Information

About Us
Scientist with a Heart- Dr. Y K Hamied
90 years of caring for life
Milestones and Awards

Our Presence

Our Presence
Australia
Brazil
Europe
Germany
Ghana
Kenya
Malaysia
Morocco
Nepal
South Africa
Spain
Sri Lanka
Uganda
United Kingdom
USA

Our Offerings

Our Offerings
Our Therapies
Respiratory
Asthma
COPD
Nebulization
Paediatric Asthma
HIV/AIDS
Oncology
Other Therapies
AMR
Cipla Generics
Products
Cipcal
Easylax
Easylax-L
OTC – Cipla Health
Cipla Diagnostics
API
Covid Care

Sustainability

Sustainability
Accelerated Community Well-being
Championing Climate Positivity
Community Initiatives
Employee Initiatives
Enhancing Access and Affordability
Raising the Bar on Governance

Investor Information

Investors
Financials & Filings
Quarterly Results
Investor Presentation
Annual Reports
Scheme of Arrangement
Corporate Governance
Disclosure under regulation 46 of SEBI
Cipla At a Glance
Investor Resources
Shareholding Pattern
Intimation to stock Exchanges
Unclaimed Data
Investor Contact
Disclaimer

Media

Media Center
Media Releases
In the News

Career Sitemap

Careers
Life at Cipla
Business Functions
Diversity & Inclusion
Holistic Wellbeing
Cipla University
Join Us

Corporate Social Responsibility

CSR-Cipla Foundation
Cipla Palliative Care
Annual Update 2023-24
CSR Policy
CSR Committee
Approved CSR Projects
- 2024-25
- 2023-24
- 2022-23
- 2021-22

Quick Links - Footer

Privacy Policy
Disclaimer
Contact Us
Sitemap
Beware of Recruitment Fraud
Drug Safety Reporting

Chatbot API

Terms & Condition
Privacy Policy
Disclaimer
Terms of Use

Related Links

breathefree.com
ciplamed.com

© Copyright 2019 Cipla. All rights reserved

Digital Partner : Indus Net Technologies

Subscribe to Cipla Newsletter

Email Address

Mobile Footer Menu

Remdesivir Supply Details - Maharashtra
Caution Notice - "Recruitment Fraud"
Contact Us
Disclaimer
Privacy Policy

© Copyright 2019 Cipla. All rights reserved

×

We use cookies on this site to enhance your user experience

By continuing to browse our website, you agree to the use of cookies. More info

Accept All Cookies

Reject Cookies

Manage Preferences

Cookie Preferences

×

Necessary Cookies (Always Active)

Analytics Cookies

Save Preferences